Catalyst Wire Dossier Catalyst Wire Dossier

Ingavirin

· Valenta Pharm JSC
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Ingavirin, covering 2016-06-09 to 2024-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections [Phase 4]

See pricing